Global Biomarkers and Companion Diagnostics in Oncology Market 2019 by Industry Access Trends, Market Drivers, Barriers and Unmet Needs, Key Products and Companies
A biomarker is a defined molecular characteristic, for example a genetic mutation, that can tell a physician more about a patient's disease state, or how they might respond to treatment. Predictive biomarkers indicate how likely a patient is to respond to a treatment, and are used in clinical decision making. In some cases, a patient must possess a particular biomarker to receive a particular drug. For example, breast cancer patients must test positive for HER2 in order to receive anti-HER2...
View full press release